- Home
- SGHT vs ACRE Comparison
SGHT vs ACRE Comparison
Compare SGHT & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- ACRE
- Stock Information
- Founded
- SGHT 2011
- ACRE 2011
- Country
- SGHT United States
- ACRE United States
- Employees
- SGHT N/A
- ACRE N/A
- Industry
- SGHT Medical Specialities
- ACRE Real Estate Investment Trusts
- Sector
- SGHT Health Care
- ACRE Real Estate
- Exchange
- SGHT Nasdaq
- ACRE Nasdaq
- Market Cap
- SGHT 304.4M
- ACRE 337.1M
- IPO Year
- SGHT 2021
- ACRE 2012
- Fundamental
- Price
- SGHT $2.89
- ACRE $5.91
- Analyst Decision
- SGHT Buy
- ACRE Hold
- Analyst Count
- SGHT 7
- ACRE 7
- Target Price
- SGHT $5.10
- ACRE $6.80
- AVG Volume (30 Days)
- SGHT 260.5K
- ACRE 781.8K
- Earning Date
- SGHT 03-06-2025
- ACRE 02-20-2025
- Dividend Yield
- SGHT N/A
- ACRE 16.91%
- EPS Growth
- SGHT N/A
- ACRE N/A
- EPS
- SGHT N/A
- ACRE N/A
- Revenue
- SGHT $79,543,000.00
- ACRE $39,423,000.00
- Revenue This Year
- SGHT $2.13
- ACRE N/A
- Revenue Next Year
- SGHT $7.99
- ACRE N/A
- P/E Ratio
- SGHT N/A
- ACRE N/A
- Revenue Growth
- SGHT N/A
- ACRE N/A
- 52 Week Low
- SGHT $2.68
- ACRE $5.33
- 52 Week High
- SGHT $8.45
- ACRE $10.53
- Technical
- Relative Strength Index (RSI)
- SGHT 26.68
- ACRE 43.41
- Support Level
- SGHT $2.68
- ACRE $5.33
- Resistance Level
- SGHT $3.34
- ACRE $5.99
- Average True Range (ATR)
- SGHT 0.16
- ACRE 0.19
- MACD
- SGHT -0.03
- ACRE 0.03
- Stochastic Oscillator
- SGHT 20.38
- ACRE 65.34
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.